Shares of Medtronic MDT rose 0.2% in pre-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were down 22.14% over the past year to $1.02, which beat the estimate of $0.80.
Revenue of $7,647,000,000 decreased by 0.77% from the same period last year, which beat the estimate of $7,100,000,000.
Outlook
Medtronic hasn't issued any earnings guidance for the time being.
Medtronic hasn't issued any revenue guidance for the time being.
Details Of The Call
Date: Nov 24, 2020
Time: 08:00 AM
ET Webcast URL: https://vimeo.com/479890065
Recent Stock Performance
52-week high: $122.15
52-week low: $72.13
Price action over last quarter: Up 6.92%
Company Description
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.